The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis
Abstract
OBJECTIVE: To analyse the bacteriological outcome of combination versus single-agent antimicrobial treatment in staphylococcal endocarditis. PATIENTS AND METHODS: Retrospective review of 152 episodes: 91 cases of native valve endocarditis (NVE), 74 due to Staphylococcus aureus and 17 due to coagulase-negative staphylococci (CoNS); and 61 cases of prosthetic valve endocarditis (PVE), 29 due to S. aureus and 32 due to CoNS. RESULTS: Valves from patients with S. aureus NVE treated with any kind of combination antibiotic treatment were no more likely to be culture-negative than those treated with a single agent [19 (45%) of 42 versus 13 (41%) of 32; P = 0.69]. This finding remained unchanged when cases of CoNS NVE were added to the S. aureus group. In PVE, after adjusting for duration of treatment, valves from patients receiving any kind of combination treatment were 5.9 times (95% confidence interval 1.3-27.5) more likely to be culture-negative than those receiving monotherapy (P = 0.024). Patients treated for >14 days were more likely to be culture-negative than those treated for <or=14 days [49 (83%) of 59 versus 29 (31%) of 93; P < 0.001]. CONCLUSIONS: In staphylococcal NVE, combination treatment is not superior to monotherapy in sterilizing infected valves, but in PVE combination treatment confers an advantage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Experimental IE models caused by methicillin-resistant staphylococci demonstrated that vancomycin combined with rifampin and gentamicin is the optimal regimen, and limited clinical reports support this approach.183”
Citations
Cites
Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027
Infective Endocarditis in Adults
Mylonakis, E., & Calderwood, S. B. (2001) · New England Journal of Medicine · doi:10.1056/nejmra010082 · Cited by 1,324
Wilson, W. R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530210060032 · Cited by 492
KARCHMER, A. W., ARCHER, G. L., & DISMUKES, W. E. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-4-447 · Cited by 395
Widmer, A. F., Frei, R., Rajacic, Z., & Zimmerli, W. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.1.96 · Cited by 315
Antimicrobial Therapy of Experimental Endocarditis Caused by Staphylococcus aureus
Sande, M. A., & Johnson, M. L. (1975) · Journal of Infectious Diseases · doi:10.1093/infdis/131.4.367 · Cited by 158
Chuard, C., Herrmann, M., Vaudaux, P., Waldvogel, F. A., & Lew, D. P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.12.2611 · Cited by 143
Lucet, J. C., Herrmann, M., Rohner, P., Auckenthaler, R., Waldvogel, F. A., & Lew, D. P. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.12.2312 · Cited by 142
Combination Antibiotic Therapy for Infective Endocarditis
Le, T., & Bayer, A. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367661 · Cited by 126
Native valve endocarditis due to coagulase-negative staphylococci
Caputo, G. M., Archer, G. L., Calderwood, S. B., DiNubile, M. J., & Karchmer, A. W. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90889-8 · Cited by 116
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Holland, T. L., Baddour, L. M., Bayer, A. S., Hoen, B., Miro, J. M., & Fowler, V. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.59 · Cited by 406
Initial Low‐Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is Nephrotoxic
Cosgrove, S. E., Vigliani, G. A., Campion, M., Fowler, Jr., Abrutyn, E., Corey, G. R., Levine, D. P., Rupp, M. E., Chambers, H. F., Karchmer, A. W., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/597031 · Cited by 309
Update on Infective Endocarditis
Bashore, T. M., Cabell, C., & Fowler, Jr. (2006) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2005.12.001 · Cited by 227
Chu, V. H., Miro, J. M., Hoen, B., Cabell, C. H., Pappas, P. A., Jones, P., Stryjewski, M. E., Anguera, I., Braun, S., Muñoz, P., et al. (2009) · Heart · doi:10.1136/hrt.2008.152975 · Cited by 109
Self-citation
Metadata
- Authors
- Drinkovic, D.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-09-30
- Volume
- 52
- Issue
- 5
- Pages
- 820-825
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2163218775
- Cited by
- 59
- References
- 21
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 6 · 2023: 3 · 2022: 2 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 2 · 2012: 2
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- staphylococcal endocarditis, Staphylococcus aureus, coagulase-negative staphylococci, native valve endocarditis, prosthetic valve endocarditis, combination antibiotic therapy, monotherapy, treatment duration
- MeSH terms
- Anti-Bacterial Agents, Coagulase, Culture Media, Drug Therapy, Combination, Endocarditis, Bacterial, Heart Valves, Humans, Staphylococcal Infections, Staphylococcus, Staphylococcus aureus, Prosthesis-Related Infections, Treatment Outcome, Heart Valve Prosthesis Implantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis. https://app.cochat.ai/papers/10.1093/jac/dkg440
- The paper
- Drinkovic, D. (2003). Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkg440
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.